Benzinga's Top Upgrades

by Lisa Levin, Benzinga Editor

January 8, 2015 9:09 AM | 1 min read | Make a Comment

Analysts at Jefferies upgraded

Eli Lilly and CompanyLLY

from Hold to Buy. The price target for Eli Lilly has been raised from $75 to $80. Eli Lilly's shares closed at $69.23 yesterday. Analysts at Nomura upgraded

Molson Coors Brewing CompanyTAP

from Neutral to Buy. The price target for Molson Coors Brewing has been raised from $70 to $85. Molson Coors Brewing's shares closed at $75.40 yesterday. Evercore Partners upgraded

SAP SESAP

from Hold to Buy. SAP's shares closed at $65.09 yesterday. Analysts at Leerink Swann upgraded

Boston Scientific CorporationBSX

from Market Perform to Outperform. The price target for Boston Scientific has been raised from $15 to $18. Boston Scientific's shares closed at $14.03 yesterday.

Market News and Data brought to you by Benzinga APIs